Literature DB >> 8637721

Activation of the JNK pathway by distantly related protein kinases, MEKK and MUK.

S Hirai1, M Izawa, S Osada, G Spyrou, S Ohno.   

Abstract

JNK/SAPKs are identified as new members of the MAPK family; they phosphorylate c-Jun protein in response to several cellular stimuli including ultraviolet irradiation, TNF and osmotic shock. We have identified a protein kinase, MUK, as an activator of the JNK-pathway, whose kinase domain shows significant homology to MAPKKK-related proteins such as c-Raf and MEKK. The over-expression of MUK or MEK kinase (MEKK) in NIH3T3 or COS1 cells results in the activation of JNK1 and the accumulation of a hyper-phosphorylated form of c-Jun. While MEKK also activates the ERK pathway, MUK is a rather selective activator of the JNK pathway. On the other hand, c-Raf activates the JNK pathway only slightly despite its remarkable ability to activate the ERK pathway. Even though we originally identified MUK as a MAPKKK-related protein kinase, a greater similarity to mixed lineage kinase (MLK) is found not only in the catalytic domain but also in the 'leucine-zipper'-like motifs located at the C-terminal side of the catalytic domain. The structural divergence between MUK and MEKK reveals the multiplicity of signaling pathways that activate JNK/SAPKs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8637721

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury.

Authors:  Vera Valakh; Erin Frey; Elisabetta Babetto; Lauren J Walker; Aaron DiAntonio
Journal:  Neurobiol Dis       Date:  2015-02-26       Impact factor: 5.996

2.  Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.

Authors:  A Mudher; S Chapman; J Richardson; A Asuni; G Gibb; C Pollard; R Killick; T Iqbal; L Raymond; I Varndell; P Sheppard; A Makoff; E Gower; P E Soden; P Lewis; M Murphy; T E Golde; H T Rupniak; B H Anderton; S Lovestone
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

3.  Evidence for a role of mixed lineage kinases in neuronal apoptosis.

Authors:  M Mota; M Reeder; J Chernoff; C E Bazenet
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

4.  Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components.

Authors:  D Nihalani; D Meyer; S Pajni; L B Holzman
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

5.  The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases.

Authors:  C Tournier; A J Whitmarsh; J Cavanagh; T Barrett; R J Davis
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  Microtubule depolymerization in Caenorhabditis elegans touch receptor neurons reduces gene expression through a p38 MAPK pathway.

Authors:  Alexander Bounoutas; John Kratz; Lesley Emtage; Charles Ma; Ken C Nguyen; Martin Chalfie
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-22       Impact factor: 11.205

Review 7.  The IRS-signalling system: a network of docking proteins that mediate insulin action.

Authors:  M F White
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

8.  MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration.

Authors:  Y Xia; C Makris; B Su; E Li; J Yang; G R Nemerow; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 9.  Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling.

Authors:  D T Denhardt
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

10.  DCX, a new mediator of the JNK pathway.

Authors:  Amos Gdalyahu; Indraneel Ghosh; Talia Levy; Tamar Sapir; Sivan Sapoznik; Yael Fishler; David Azoulai; Orly Reiner
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.